Serum α2-HS glycoprotein concentration in patients with hematological malignancies - A follow-up study

L. Kalabay, K. Cseh, S. Benedek, S. Fekete, T. Masszi, K. Herjeczki, T. Pozsonyi, L. Jakab, L. Jakab

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

We observed significantly reduced serum α2-HS glycoprotein concentrations in patients with acute lymphocytic, acute nonlymphocytic, chronic granulocytic and chronic myelomonocytic leukemias, Hodgkin's and non-Hodgkin's lymphomas, myelofibrosis, and multiple myeloma, but not in patients with chronic lymphocytic leukemia and polycythemia vera, as compared with healthy controls. We followed the serum level of the protein for 18 months. Patients with infectious complications, those receiving cytostatic treatment, and those in the preterminal period had further reduced serum α2-HS glycoprotein levels. The reduction of serum α2-HS glycoprotein concentration was primarily due to decreased production caused by infiltration of the liver, a hepatotoxic effect of cytostatic treatment, and, to a lesser degree, to increased consumption. We found statistically significant negative correlations between serum α2-HS glycoprotein concentration and erythrocyte sedimentation rate, serum aspartate aminotransferase and alkaline phosphatase activities, and IgG and IgM concentrations. The determination of the α2-HS glycoprotein concentration is useful for the assessment and follow-up of the clinical status and therapy of patients with hematological malignancies and also has prognostic significance.

Original languageEnglish
Pages (from-to)264-269
Number of pages6
JournalAnnals of Hematology
Volume63
Issue number5
DOIs
Publication statusPublished - Nov 1 1991

Keywords

  • Leukemias
  • Lymphomas
  • Multiple myeloma
  • Myelofibrosis
  • Polycythemia vera
  • α- HS glycoprotein

ASJC Scopus subject areas

  • Hematology

Fingerprint Dive into the research topics of 'Serum α<sub>2</sub>-HS glycoprotein concentration in patients with hematological malignancies - A follow-up study'. Together they form a unique fingerprint.

  • Cite this